BCL2 and acute myeloid leukemia: In AML, suppression of apoptosis by expression of anti-apoptotic members of the Bcl-2 family is one of the principal mechanisms underlying disease pathogenesis, resistance and relapse, making the anti-apoptotic members of the family attractive therapeutic targets5,6.